Binding mode of the breakthrough inhibitor AZD9291 to epidermal growth factor receptor revealed. [electronic resource]
Producer: 20160913Description: 539-544 p. digitalISSN:- 1095-8657
- Acrylamides -- metabolism
- Aniline Compounds -- metabolism
- Antineoplastic Agents -- pharmacology
- Crystallography, X-Ray
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- antagonists & inhibitors
- Erlotinib Hydrochloride -- pharmacology
- Gefitinib
- Humans
- Lung Neoplasms -- drug therapy
- Protein Binding -- physiology
- Protein Kinase Inhibitors -- pharmacology
- Quinazolines -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.